{"id":386145,"date":"2020-11-20T13:54:14","date_gmt":"2020-11-20T18:54:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386145"},"modified":"2020-11-20T13:54:14","modified_gmt":"2020-11-20T18:54:14","slug":"lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/","title":{"rendered":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering"},"content":{"rendered":"
\n

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (\u201cNASDAQ\u201d) under the symbol \u201cLSAQ.\u201d<\/p>\n

LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the \u201cUnderwriters\u201d). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any.<\/p>\n

The offering is expected to close on or about November 24, 2020, subject to customary closing conditions.<\/p>\n

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on\u00a0November 20, 2020. The offering is being made only by means of a prospectus, copies of which may be obtained from LifeSci Capital LLC, 250 West 55th Street, 34th Floor #3401, New York, NY 10019, Attn: Syndicate Department, or Ladenburg Thalmann & Co. Inc., 277 Park Avenue, 26th Floor, New York, NY 10172, Attn: Syndicate Department. Copies of the registration statement can be accessed through the SEC’s website at\u00a0www.sec.gov<\/strong><\/a>.<\/p>\n

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/p>\n

\n About LifeSci Acquisition <\/strong>
\n II <\/strong>
\n Corp.<\/strong>
\n
LifeSci Acquisition II Corp. (NASDAQ:LSAQ<\/a><\/strong>) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company intends to pursue prospective targets that are focused on healthcare innovation in North America or Europe. For more information, please visit\u00a0www.lifesciacquisition.com<\/strong><\/a>.<\/strong><\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the LifeSci Acquisition II Corp.\u2019s initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. LifeSci Acquisition II Corp. expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in LifeSci Acquisition II Corp.\u2019s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.<\/p>\n

\n Media Contact<\/strong>
\n
Kristin Politi, Ph.D.
LifeSci Communications
(646) 876-4783
kpoliti@lifescicomms.com<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (\u201cNASDAQ\u201d) under the symbol \u201cLSAQ.\u201d LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the \u201cUnderwriters\u201d). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any. The offering is expected to close on or about November 24, 2020, subject to customary closing conditions. … <\/p>\n

Continue reading “LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386145","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (\u201cNASDAQ\u201d) under the symbol \u201cLSAQ.\u201d LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the \u201cUnderwriters\u201d). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any. The offering is expected to close on or about November 24, 2020, subject to customary closing conditions. … Continue reading "LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-20T18:54:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering\",\"datePublished\":\"2020-11-20T18:54:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/\"},\"wordCount\":455,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/\",\"name\":\"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==\",\"datePublished\":\"2020-11-20T18:54:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/","og_locale":"en_US","og_type":"article","og_title":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk","og_description":"NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (\u201cNASDAQ\u201d) under the symbol \u201cLSAQ.\u201d LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the \u201cUnderwriters\u201d). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any. The offering is expected to close on or about November 24, 2020, subject to customary closing conditions. … Continue reading \"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-20T18:54:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering","datePublished":"2020-11-20T18:54:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/"},"wordCount":455,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/","name":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==","datePublished":"2020-11-20T18:54:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDAzNCMzODM3OTkwIzUwMDA3NTg0Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifesci-acquisition-ii-corp-announces-pricing-of-75-million-initial-public-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386145"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386145\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}